Synosia Therapeutics

Developer of therapeutics for the treatment of CNS disorders

placeBasel, Basel Stadt, Switzerland calendar_todayFounded 2005 groups17 employees language synosia.com

Innovation

8 patent families (2 granted) — focus: Human necessities, Chemistry & metallurgy; filing pace slowing. Cited 96 times.

YearFilings
20122
20132
20142
20221

Investor mix

8 investors on record; lead investors include Investor, Aravis, UCB; 3 have since exited.

Investor typeCountShare
Venture capital338%
Private equity225%
Other / undisclosed338%
Coming soon